Comparative 3‐Year Allograft Outcomes for Recipients of Kidneys From SARS‐CoV‐2 NAT‐Positive Donors
Open Access
- 13 March 2026
- journal article
- Published by Wiley in Transplant Infectious Disease
- Vol. 28 (4) , e70202
Abstract
Background: Data demonstrates safety and short‐term success of kidney transplantation (KT) from SARS‐CoV‐2 NAT‐positive organ donors (NAT+) compared to NAT‐negative donors. However, detailed reports of longer‐term graft outcomes are limited and lack granular data on donor SARS‐CoV‐2 infection severity. Methods: We retrospectively reviewed records from 220 recipients of KT (KTRs) at our institution from February 1, 2021, to January 31, 2022. We compared 1‐ and 3‐year allograft‐specific outcomes for KTRs from NAT+ ( N = 59), CoV‐COD (COVID as cause of death) ( N = 56), and NAT‐neg ( N = 105) donors. We reviewed and compared pathology findings for allograft biopsies for all groups up to 1 year. We examined the association of eGFR at 3 years with CoV‐donor status using multivariable linear regression. Results: At 1 year, there was no difference in rejection or kidney pathologies by CoV‐donor status. At 3 years, there was no difference in patient death or graft loss by group. For subjects without graft loss, eGFR at 3 years for NAT+, CoV‐COD, and NAT‐neg donors was 54.8 (21.8), 45.6(17.9), and 48.4 (23.3) mL/min/m 2 , respectively ( p = 0.61). On multivariable analysis, there was no significant association of eGFR with CoV‐donor status. Conclusions: We found no significant difference in pathological findings or 3‐year allograft outcomes following KT from NAT‐negative, NAT+, or CoV‐COD donors. Despite modestly reduced eGFR for COV‐COD on unadjusted analysis, kidneys from donors with a spectrum of COVID severities did not experience significantly poorer allograft outcomes over 3 years. imageKeywords
This publication has 21 references indexed in Scilit:
- Early Outcomes of Adult Heart Transplantation From COVID-19 Infected DonorsJACC, 2023
- Patterns in Use and Transplant Outcomes Among Adult Recipients of Kidneys From Deceased Donors With COVID-19JAMA Network Open, 2023
- Kidney outcome after mild to moderate COVID-19Nephrology Dialysis Transplantation, 2023
- Detection of Transmissible Severe Acute Respiratory Syndrome Coronavirus-2 From Deceased Kidney Donors: Implications for Kidney Transplant RecipientsTransplantation, 2022
- Transplanting Kidneys From Donors With SARS-CoV-2 RNA Positivity in Brazil: Early Success Under a Detailed Surveillance ApproachTransplantation, 2022
- COVID-19 infection triggering Thrombotic Thrombocytopenic PurpuraIDCases, 2021
- A call to routinely test lower respiratory tract samples for SARS-CoV-2 in lung donorsAmerican Journal of Transplantation, 2021
- Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through TransplantationTransplantation, 2021
- Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testingAmerican Journal of Transplantation, 2021
- Pathology of COVID-19-associated acute kidney injuryClinical Kidney Journal, 2021